Stock detail
Abcellera Biologics (ABCL) stock price, chart, and key data
View Abcellera Biologics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Abcellera Biologics
ABCL · XNAS
$10.41
-0.48%
-$0.05
Key metrics
52-week range
$11.50 - $1.00
Close price
$10.46
Market cap
$3.4B
P/E ratio
-19.37
Beta
0.36
About the company
Abcellera Biologics Inc
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$17.17
7
Buy
/ 7
Recent calls
09/02/2026
Truist Financial
Srikripa Devarakonda
Buy · Price target $30.00
08/17/2026
BMO Capital
Evan Seigerman
Buy · Price target $15.00
08/10/2026
JonesTrading
Debanjana Chatterjee
Buy · Price target $25.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
No holder data is available for this category yet.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app